244 related articles for article (PubMed ID: 21256922)
21. Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine.
de Lucena D; Fernandes BS; Kunz M; Fries GR; Stertz L; Aguiar B; Pfaffenseller B; Gama CS
J Clin Psychiatry; 2010 Jan; 71(1):91-2. PubMed ID: 20129011
[No Abstract] [Full Text] [Related]
22. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
[TBL] [Abstract][Full Text] [Related]
23. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients.
Huang TL; Lee CT
J Psychiatr Res; 2006 Oct; 40(7):664-8. PubMed ID: 16386272
[TBL] [Abstract][Full Text] [Related]
24. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
25. Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment.
Lee AH; Lange C; Ricken R; Hellweg R; Lang UE
J Clin Psychopharmacol; 2011 Jun; 31(3):334-6. PubMed ID: 21508862
[TBL] [Abstract][Full Text] [Related]
26. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
[TBL] [Abstract][Full Text] [Related]
27. Clozapine and global cognition in schizophrenia.
Rajji TK; Uchida H; Ismail Z; Ng W; Mamo DC; Remington G; Pollock BG; Mulsant BH
J Clin Psychopharmacol; 2010 Aug; 30(4):431-6. PubMed ID: 20631560
[TBL] [Abstract][Full Text] [Related]
28. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
29. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
Zakharyan R; Boyajyan A
Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
[TBL] [Abstract][Full Text] [Related]
30. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
[TBL] [Abstract][Full Text] [Related]
31. Psychotropic drugs on in vitro brain-derived neurotrophic factor production in whole blood cell cultures from healthy subjects.
Lee BH; Myint AM; Kim YK
J Clin Psychopharmacol; 2010 Oct; 30(5):623-7. PubMed ID: 20814321
[TBL] [Abstract][Full Text] [Related]
32. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.
Dias VV; Brissos S; Frey BN; Andreazza AC; Cardoso C; Kapczinski F
Bipolar Disord; 2009 Sep; 11(6):663-71. PubMed ID: 19689509
[TBL] [Abstract][Full Text] [Related]
33. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
34. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.
Fernandes BS; Steiner J; Berk M; Molendijk ML; Gonzalez-Pinto A; Turck CW; Nardin P; Gonçalves CA
Mol Psychiatry; 2015 Sep; 20(9):1108-19. PubMed ID: 25266124
[TBL] [Abstract][Full Text] [Related]
35. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
[TBL] [Abstract][Full Text] [Related]
36. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet.
Guimarães LR; Jacka FN; Gama CS; Berk M; Leitão-Azevedo CL; Belmonte de Abreu MG; Lobato MI; Andreazza AC; Ceresér KM; Kapczinski F; Belmonte-de-Abreu P
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1595-8. PubMed ID: 18582525
[TBL] [Abstract][Full Text] [Related]
38. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone.
Tracy JI; Monaco CA; Abraham G; Josiassen RC; Pollock BG
J Clin Psychiatry; 1998 Apr; 59(4):184-8. PubMed ID: 9590669
[TBL] [Abstract][Full Text] [Related]
39. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
40. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse.
Jockers-Scherübl MC; Danker-Hopfe H; Mahlberg R; Selig F; Rentzsch J; Schürer F; Lang UE; Hellweg R
Neurosci Lett; 2004 Nov; 371(1):79-83. PubMed ID: 15500971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
